Alterity Therapeutics Ltd (ATHE) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $3.48
• Market Cap: $62.17M
• EPS: $-0.61
• 52-Week High: $7.00
• 52-Week Low: $2.52

About Alterity Therapeutics Ltd

Alterity Therapeutics Ltd is a biopharmaceutical company based in Melbourne, Australia, specializing in the development of innovative therapies for Parkinson's disease and other neurodegenerative disorders. The company focuses on addressing significant unmet medical needs through its proprietary drug candidates and cutting-edge research programs. Committed to scientific excellence and collaborative approaches, Alterity strives to enhance patients' quality of life while advancing the field of ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Alterity Therapeutics Ltd and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ATHE pay dividends?

Alterity Therapeutics Ltd (ATHE) does not currently pay a regular dividend.

What is ATHE's market cap?

Alterity Therapeutics Ltd (ATHE) has a market capitalization of $62.17M with a current stock price of $3.48.